Related Experiment Video
Updated: Jun 14, 2026
13:51
The MultiBac Protein Complex Production Platform at the EMBL
Published on: July 11, 2013
15.9K
Improving the production of BaEV lentivirus by comprehensive optimization
Jinxue Li1, Wenqiang Xu1, Shengtao Luo1
1Shandong Lishan Biotechnology Co., Ltd, Jinan 250013, PR China.
Journal of Virological Methods
|December 30, 2024
Summary
Researchers optimized BaEV lentivirus production, overcoming low yield issues. This significantly increased lentivirus titers, enhancing its utility for cell and gene therapies.
Area of Science:
- Biotechnology
- Molecular Biology
- Virology
Background:
- The cell and gene therapy sector requires efficient lentiviral vectors for diverse cell types.
- BaEV lentiviruses exhibit superior infectivity in hematopoietic stem cells, B cells, and NK cells compared to VSV-G lentiviruses.
- Low virus yield and cellular toxicity (syncytium formation, apoptosis) hinder BaEV lentivirus production.
Purpose of the Study:
- To comprehensively improve the low production yield of BaEV lentivirus.
- To optimize BaEV lentivirus production and purification processes for enhanced therapeutic applications.
Main Methods:
- Optimized BaEV lentivirus production by adjusting cell inoculation density, BaEV plasmid concentration, and harvest timing.
- Developed an optimized purification method for the lentivirus solution.
Main Results:
- Achieved a maximum BaEV lentivirus titer of 4.43E+06 IU/ml under optimized production conditions, a 369-fold increase.
- The optimized purification method resulted in an infection titer of 1.00E+08 IU/ml, a 10300-fold enhancement over pre-optimization levels.
Conclusions:
- The study successfully addressed BaEV lentivirus production challenges, significantly boosting virus yield and titer.
- Optimized BaEV lentivirus production and purification offer a more efficient and scalable vector for cell and gene therapy development.
